HIV microbicide study gets FDA approval
BY Advocate.com Editors
August 06 2003 12:00 AM ET
The Food and Drug Administration on Monday gave approval to Australia-based Starpharma to begin human trials in the U.S. of its HIV microbicide gel called VivaGel, CNN.com reports. The compound was shown to be 100% effective in animals in preventing HIV, genital herpes, and chlamydia infections. The gel will be studied in women for the prevention of vaginal HIV infections. The company hasn't commented on whether the compound will be evaluated to prevent HIV infections through anal sex. Starpharma officials say if the trials are successful, a prescription-only version of the product could be available within three years, with an over-the-counter version possible in about five years.
- Kris Humphries Doesn't Support Bruce Jenner
- Check Out The Enormous Support for Bruce Jenner from Celebs on Twitter
- Reba McEntire: First Time I Saw a Reba Drag Queen 'It Really Ticked Me Off'
- Bruce Jenner: 'I'm A Woman'
- Ted Cruz/OUT NYC Fallout: Broadway Cares Cancels Benefit at Hotel
- Op-ed: Michfest's Founder Chose to Shut Down Rather Than Change With the Times